ABBOTT LABORATORIES — Director's Dealing 2008

May 17, 2008

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: ABBOTT LABORATORIES (ABT)
CIK: 0000001800
Period of Report: 2008-05-14

Reporting Person: Tyree James L (Executive Vice President)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2008-05-14	Common shares without par value	M	2792	$41.95	Acquired	120269	Direct
2008-05-14	Common shares without par value	M	10697	$42.83	Acquired	130966	Direct
2008-05-14	Common shares without par value	F	11725	$54.40	Disposed	119241	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2008-05-14	Option (right to buy)	$41.95	M	2792	Disposed	2013-02-13	Common shares (2792)	Direct
2008-05-14	Option (right to buy)	$42.83	M	10697	Disposed	2013-02-13	Common shares (10697)	Direct
2008-05-14	Option (right to buy)	$54.40	A	11725	Acquired	2013-02-13	Common shares (11725)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
Common shares without par value	1169	Indirect

Footnotes

F1: Balance in the Abbott Laboratories Stock Retirement Trust as of May 14, 2008.

F2: Employee stock option, including a replacement option feature, granted pursuant to the Abbott Laboratories 1996 Incentive Stock Program, in a transaction exempt from Section 16 under Rule 16b-3.